Light therapy for multiple sclerosis-associated fatigue: a randomized, controlled phase II trial

Light therapy for multiple sclerosis-associated fatigue: a randomized, controlled phase II trial

Background Bright white light therapy (LT) can improve fatigue in several disease states but has not been studied in multiple sclerosis (MS). Objective To determine whether controlled home-based LT is feasible, tolerable, and well-adhered to in MS-associated fatigue. Methods A randomized, controlled...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of neurology 2020-08, Vol.267 (8), p.2319-2327
Hauptverfasser: Mateen, Farrah J., Vogel, Andre C., Kaplan, Tamara B., Hotan, Gladia C., Grundy, Sara J., Holroyd, Kathryn B., Manalo, Natalie, Stauder, Matthew, Videnovic, Aleksandar
Format: Artikel
Sprache:eng
Schlagworte:
Fatigue
Headache
Light therapy
Medicine
Medicine & Public Health
Multiple sclerosis
Neurology
Neuroradiology
Neurosciences
Original Communication
Placebos
Quality of life
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background Bright white light therapy (LT) can improve fatigue in several disease states but has not been studied in multiple sclerosis (MS). Objective To determine whether controlled home-based LT is feasible, tolerable, and well-adhered to in MS-associated fatigue. Methods A randomized, controlled trial of twice-daily 1-h bright white LT (BWLT) (10,000 lx, active arm) versus dim red LT (DRLT) (
ISSN:0340-5354
1432-1459
DOI:10.1007/s00415-020-09845-w